NeOnc Technologies Holdings is trading higher alongside biotech-sector strength, at $3.68 (+6.67%).

  • XBI was reported up 2.61% pre-market.
  • No fresh September 23 company-specific announcement, earnings release, or FDA update was identified.
  • Recent company news includes preferred-stock redemption and insider buying.